Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms
Ciarán Martin Fitzpatrick, B. Anderson, Gabrielle Agin-Liebes, Joseph Guydish
Journal of Psychoactive Drugs January 27, 2022 DOI: 10.1080/02791072.2021.1983673 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A person with obsessive-compulsive disorder |
| Intervention | psilocybin-containing mushrooms |
| Topics | Psilocybin |
| Keywords | Consumption sociology Hallucinogen |
| Citations | 1 |
| Key findings | Consumption of psilocybin-containing mushrooms was associated with reduction of obsessive-compulsive disorder symptoms in a single case. |
Abstract
The Journal of Psychoactive Drugs published a case study reporting reduction of obsessive-compulsive disorder (OCD) symptoms after consumption of psilocybincontaining mushrooms (Lugo-Radillo & Cortes-Lopez, 2021).We subsequently received a letter suggesting that psychedelic research has progressed beyond case studies, and recommending that journals focus on publication of clinical trials rather than case reports.